# Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

> **NCT00769990** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Masonic Cancer Center, University of Minnesota**

## Conditions studied

- Breast Cancer
- Kidney Cancer
- Lung Cancer
- Melanoma
- Metastatic Cancer
- Pain
- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** genistein
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00769990
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-09
- **Primary completion:** 2009-11
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient accrual.
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769990, "Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00769990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*